171 related articles for article (PubMed ID: 21546718)
1. Clinical relevance of serum vascular endothelial growth factor and interleukin-6 in patients with colorectal cancer.
Eldesoky A; Shouma A; Mosaad Y; Elhawary A
Saudi J Gastroenterol; 2011; 17(3):170-3. PubMed ID: 21546718
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of preoperative serum vascular endothelial growth factor, interleukin-6, and C-reactive protein level in colorectal cancer.
Kwon KA; Kim SH; Oh SY; Lee S; Han JY; Kim KH; Goh RY; Choi HJ; Park KJ; Roh MS; Kim HJ; Kwon HC; Lee JH
BMC Cancer; 2010 May; 10():203. PubMed ID: 20465852
[TBL] [Abstract][Full Text] [Related]
3. Serum vascular endothelial growth factor-C and vascular endothelial growth factor level in patients with colorectal carcinoma and clinical significance.
Xu T; Chen D
J Huazhong Univ Sci Technolog Med Sci; 2006; 26(3):329-31, 355. PubMed ID: 16961284
[TBL] [Abstract][Full Text] [Related]
4. Progressive increase of matrix metalloprotease-9 and interleukin-8 serum levels during carcinogenic process in human colorectal tract.
Biasi F; Guina T; Maina M; Nano M; Falcone A; Aroasio E; Saracco GM; Papotti M; Leonarduzzi G; Poli G
PLoS One; 2012; 7(7):e41839. PubMed ID: 22848630
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of plasma vascular endothelial growth factor in gastrointestinal cancer.
Hyodo I; Doi T; Endo H; Hosokawa Y; Nishikawa Y; Tanimizu M; Jinno K; Kotani Y
Eur J Cancer; 1998 Dec; 34(13):2041-5. PubMed ID: 10070308
[TBL] [Abstract][Full Text] [Related]
6. [Clinical value of preoperative serum VEGF, CRP and IL-6 levels in colorectal carcinoma].
Li ZP; Han JQ; Meng XW; Yang YF
Zhonghua Zhong Liu Za Zhi; 2010 Oct; 32(10):795-9. PubMed ID: 21163075
[TBL] [Abstract][Full Text] [Related]
7. Serum vascular endothelial growth factor-C and lymphoangiogenesis are associated with the lymph node metastasis and prognosis of patients with colorectal cancer.
Wang TB; Chen ZG; Wei XQ; Wei B; Dong WG
ANZ J Surg; 2011 Oct; 81(10):694-9. PubMed ID: 22295309
[TBL] [Abstract][Full Text] [Related]
8. Correlations of serum VEGF and MMP-2 levels with CLM in CRC patients and effects of TACE on their expressions.
Xu H; Ren YJ; Liu K; Min XL; Yang L; Zhou Y; Zheng J; Yang C
Eur Rev Med Pharmacol Sci; 2018 Jun; 22(11):3394-3401. PubMed ID: 29917190
[TBL] [Abstract][Full Text] [Related]
9. Comparison of (18)F-fluorodeoxyglucose PET/CT findings with vascular endothelial growth factors and receptors in colorectal cancer.
Kocael A; Vatankulu B; Şimşek O; Cengiz M; Kemik A; Kocael P; Halaç M; Sönmezoğlu K; Ulualp K
Tumour Biol; 2016 Mar; 37(3):3871-7. PubMed ID: 26476536
[TBL] [Abstract][Full Text] [Related]
10. Relationship between plasma levels of vascular endothelial growth factor and serum levels of interleukin-12 in patients with colorectal cancer.
Nakayama Y; Sako T; Shibao K; Onitsuka K; Nagashima N; Hirata K; Nagata N; Itoh H
Anticancer Res; 2000; 20(6A):4097-102. PubMed ID: 11131678
[TBL] [Abstract][Full Text] [Related]
11. Correlation between serum levels of interleukin-6 and vascular endothelial growth factor in gastric carcinoma.
Huang SP; Wu MS; Wang HP; Yang CS; Kuo ML; Lin JT
J Gastroenterol Hepatol; 2002 Nov; 17(11):1165-9. PubMed ID: 12453275
[TBL] [Abstract][Full Text] [Related]
12. [Clinical significance of serum vascular endothelial growth factor and interleukin-6 in multiple myeloma].
Shen JK; Dong LH; Qi H; Zhang GS
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Feb; 30(1):68-71. PubMed ID: 15871192
[TBL] [Abstract][Full Text] [Related]
13. Development of time-resolved immunofluorometric assays for vascular endothelial growth factor and application on plasma of patients with gastric tumours.
Sheng SL; Bao SH; Huang G; Wang LM
Clin Exp Immunol; 2008 Mar; 151(3):459-66. PubMed ID: 18234057
[TBL] [Abstract][Full Text] [Related]
14. High serum levels of interleukin-6 in patients with advanced or metastatic colorectal cancer: the effect on the outcome and the response to chemotherapy plus bevacizumab.
Hara M; Nagasaki T; Shiga K; Takahashi H; Takeyama H
Surg Today; 2017 Apr; 47(4):483-489. PubMed ID: 27549777
[TBL] [Abstract][Full Text] [Related]
15. Serum cytokine levels in patients with colorectal cancers according to tumor stages and VEGF gene polymorphism.
Bayhan Z; Simşek T; Ergül E; Utkan NZ; Canturk NZ; Cekmen M
Hepatogastroenterology; 2014 Oct; 61(135):1889-94. PubMed ID: 25713884
[TBL] [Abstract][Full Text] [Related]
16. Arterio-venous gradients of IL-6, plasma and serum VEGF and D-dimers in human cancer.
Salgado R; Benoy I; Weytjens R; Van Bockstaele D; Van Marck E; Huget P; Hoylaerts M; Vermeulen P; Dirix LY
Br J Cancer; 2002 Dec; 87(12):1437-44. PubMed ID: 12454774
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of serum levels of interleukin 6 and of serum and plasma levels of vascular endothelial growth factor in hormone-refractory metastatic breast cancer patients.
Bachelot T; Ray-Coquard I; Menetrier-Caux C; Rastkha M; Duc A; Blay JY
Br J Cancer; 2003 Jun; 88(11):1721-6. PubMed ID: 12771987
[TBL] [Abstract][Full Text] [Related]
18. Correlation of plasma and serum vascular endothelial growth factor levels with platelet count in colorectal cancer: clinical evidence of platelet scavenging?
George ML; Eccles SA; Tutton MG; Abulafi AM; Swift RI
Clin Cancer Res; 2000 Aug; 6(8):3147-52. PubMed ID: 10955796
[TBL] [Abstract][Full Text] [Related]
19. Association of interleukin-8 and plasminogen activator system in the progression of colorectal cancer.
Terada H; Urano T; Konno H
Eur Surg Res; 2005; 37(3):166-72. PubMed ID: 16088182
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of preoperative serum vascular endothelial growth factor levels in patients with colorectal cancer and the effect of tumor surgery.
Karayiannakis AJ; Syrigos KN; Zbar A; Baibas N; Polychronidis A; Simopoulos C; Karatzas G
Surgery; 2002 May; 131(5):548-55. PubMed ID: 12019409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
